Janssen Seeks FDA Approval For Yondelis Drug to Treat Advanced STS
Yondelis (trabectedin), a drug developed by Janssen Research & Development for the treatment of patients with advanced soft tissue sarcoma (STS), is awaiting FDA approval. …
Article Mania – Bloggers Unite India
Your Place to post Quality Articles.
Yondelis (trabectedin), a drug developed by Janssen Research & Development for the treatment of patients with advanced soft tissue sarcoma (STS), is awaiting FDA approval. …